CUSIP 09090D103COMPHGEQ3 2025
34 filings · latest Jun 23, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Johnson & Johnson | 96.9K | $50.9K |
| 2 | Carolina Wealth Advisors, LLC | 159 | $83 |
| 4 | Feb 14, 2025 | Cystic Fibrosis Foundation | 13G/A | 20.0% | 4.09M | SEC |
| 5 | Jul 17, 2024 | Orbimed Israel Biofund Gp Limited Partnership | 13D/A | 10.0% | 17.88M | SEC |
| 6 | Jul 11, 2024 | Flynn James E | 13D/A | 10.0% | 77.79M | SEC |
| 7 | May 30, 2024 | Flynn James E | 13D/A | 4.4% | 3.06M | SEC |
| 8 | Mar 26, 2024 | Cystic Fibrosis Foundation | 13G/A | 15.6% | 9.33M | SEC |
| 9 | Mar 25, 2024 | Amr Action Fund, L.P. | 13G | 5.5% | 3.05M | SEC |
| 10 | Mar 22, 2024 | Flynn James E | 13D | 5.5% | 3.06M | SEC |
See the full Schedule 13D/13G history for Biomx Inc..
Unlock full history